Biomerieux BIM

PAR: BIM | ISIN: FR0013280286 28/07/2026

74,95 EUR (+6,01%)

(+6,01%) 28/07/2026

Grafiek Biomerieux

Grafiek Biomerieux

1 dag1d 6,01%
1 week1w 6,46%
1 maand1m 7,30%
3 maanden3m 7,38%
6 maanden6m -24,52%
1 jaar1j -39,94%
5 jaar5j -21,19%

dinsdag 28 juli 2026, 07:00

Kwartaalcijfers (2de kwartaal)

Biomerieux in het nieuws

Toon enkel gratis nieuws

18 juni 2026 · bioMérieux introduces Salmonella testing kit on GENE-UP® TYPER to support root cause analysis in the food industry · Persbericht

20 april 2026 · First-of-its-Kind Health Economic Analysis Shows Early Use of Fast Diagnostics in Sepsis Care Could Save Thousands of Lives and Reduce Health System Costs Across G7 Countries · Persbericht

9 april 2026 · bioMérieux Unveils its BIOFIRE® SPOTFIRE® Molecular Testing Solution for the Pharmaceutical Industry, Redefining Rapid Mycoplasma Testing · Persbericht

18 februari 2026 · bioMérieux launches SMARTBIOME™ to help food manufacturers gain deeper insights into spoilage and protect product quality · Persbericht

26 augustus 2025 · OhioHealth Partners with bioMérieux as Newest Global Antimicrobial Stewardship Center of Excellence · Persbericht

5 augustus 2025 · bioMérieux Develops Game Changing Quality Control Solution GENE-UP® PRO HRM · Persbericht

18 maart 2025 · bioMérieux receives FDA 510(k) Clearance for its VITEK® COMPACT PRO, a new ID/AST system to fight against antimicrobial resistance · Persbericht

Profiel Biomerieux

Gezondheidstechnologie

Medische Specialiteiten

Productie van medische instrumenten

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe